Iingxaki zeMyelosuppression kunye neZiphumo ezingavumelekanga

Iziphumo zeKhemotherapy zenza ukuba i-Myelosuppression iphumelele

Inkcazo

I-Myelosuppression ichazwa njengokunciphisa amandla omnatha wethambo ukuvelisa iiseli zegazi. Kuye kwenzeka ngokuqhelekileyo ngomhlaza njengesiphumo esisecaleni lwe-chemotherapy , kodwa kukho nezinye izizathu.

Iiseli ezithintekayo kwi-Myelosuppression

Ukutshutshiswa komzimba kungabangela ukunciphisa ukuveliswa kwe:

I-Hematopoiesis, iMarrow Bone kunye ne-Myelosuppression

Ukuqonda i-myelosuppression kuyincedo ukuthetha ngomsebenzi wethambo lomongo. Ngomnatha wethambo, zonke iiseli zegazi-amangqamuzana egazi obomvu, iiseli zegazi ezimhlophe kunye neeplatelet-ziqala ngolunye uhlobo lweseli: i- hematopoietic stem cell .

Iiseli ze-Hematopoietic stem zinamandla okuguqukela kunoma yiluphi udidi lwegazi. Ezi iiseli ziyahla iindlela ezihlukeneyo njengoko zihlukana kwiiseli ezibomvu zegazi, iiplatelets, kunye neeseli ezimhlophe zegazi, ize zibe kwiiseli ezikhethekileyo ezifana neentlobo ezahlukeneyo zeeseli zegazi ezimhlophe. Kodwa zonke ziqala ngeeseli ezinamabala. I-Myelosuppression ibhekisele kwinkqubo ephazamisa la maseli, kunye. ngenxa yoko, ichaphazela zonke iintlobo ezahlukeneyo zeeseli zegazi. Ixesha elithi myeloablation libhekisela kwi- myelosuppression enzima apho kungekho zisele zegazi ezenziwe.

Izizathu

Kukho iindlela ezininzi apho umongo wethambo ungaphazamiseka ukuze ungavelisi iiseli zegazi.

Izizathu ezicacileyo zeMyelosuppression

Iinkqubo ezinokubangela ukuba i-myelosuppression ibandakanye:

Ukusilela kweeNgcilo zeGazi

Xa iiseli ezinamaqanda azinyanga kwaye zahlula kwaye zizodwa kwiindidi ezahlukileyo zeeseli zegazi (xa kukho ukunciphisa umongo we-bone okanye ukutshutshiswa kwe-myelosuppression) kuluhlu lwamathambo egazi lubizwa ngokuba:

Ngaba i-Myelosuppression efanayo ne-Immunosuppression?

Unokuzibuza ukuba ukunyanzelwa kwe-immunosuppression kunye ne-myelosuppression kuyafana. Kwimeko yokutshatyalaliswa kwe-myelosuppression, ukuveliswa kweeseli ezimhlophe zegazi kuyancipha, ngoko kuya kuba ne-immunosuppression. Kodwa ukuxilongwa kwe-immunosuppression akusoloko kuthetha ukutshutshiswa komzimba. Ngokomzekelo, iyeza (okanye enye inkqubo) inokumelana neeseli zegazi ezimhlophe okanye ezinye iindawo ezithile zesistim somzimba, kodwa angathinteli amangqamuzana egazi abomvu okanye amaplatelet.

Unyango

Unyango lwe-myelosuppression luya kubandakanya ukunyanga naziphi na izizathu zokutshutshiswa komzimba. Ukuba idibene neziyobisi okanye i-chemotherapy, unyango lumele lubekwe okanye lulibale. Ukuba kungenxa yokungena kwethambo lomnkantso, kwaye ukunyuka okuphezulu, unyango lomhlaza kwintolongo yethambo linyathelo elibaluleke kakhulu. Ukuba kubangelwa ukungaphumeleli komongo, kuya kubaluleka ukubona ukuba ukuhluleka komongo we-bone kungenakuphikiswa, kwaye ukuba akunjalo, unyango olunjengokutshintshwa kweeseli zegazi kunye nokutsalwa komongo we-bone kungadinga ukuba kuqwalaselwe.

Ngeempawu ezinxulumene nesifo sengqondo, unyango lunokuthi lujoliswe kwi-cell defence eyabangela iimpawu. Ukukhulelwa i-anemia, ukudluliselwa kwegazi, ukuxhaswa kwesebe, okanye izinto zokukhula ezinokunikezwa. Ngenxa ye-neutropenia eyenza umngcipheko wokusuleleka okanye ufikeleleko lwesifo, ukunyuka kwezinto (njenge-Neulasta) kunokusetyenziswa kwaye unyango luphathwa kakubi kunye ne-antibiotics. Kwinqanaba eliphantsi leeplatelets eziphakamisa umngcipheko wokumpontshelwa igazi kunokufuneka.

Iikhonkco ezingentla apha kwi-chemotherapy-induced anemia, neutropenia, kunye ne-thrombocytopenia icacise le mpiliso enokuthi ithathelwe ingqalelo ukuba ukutshutshiswa komzimba kuhambelana ne-chemotherapy.

Eyaziwayo ngokuba: Ukunciphisa umongo we-Bone

Imizekelo: Ngenxa yesifo esichukumisayo, u-Rick's oncologist wacebisa ukuba alinde iveki ngaphambi kokunyanga kwakhe kweyeza.

> Imithombo:

> I-Coates, T., i-Neutropenia eyenziwa ngamachiza kunye ne-Agranulocytosis. UpToDate . Ukuhlaziywa 08/01/16.

> Weinzierl, E., noD. Ukuxilongwa ngokungafaniyo kunye neMarrow Bone Ukuphononongwa kweNew-Onset-Pancytopnia. I-American Journal ye-Clinical Pathology . 2013. 139 (1): 9-29.